HealthEquity (NASDAQ:HQY) Price Target Cut to $73.00 by Analysts at JPMorgan Chase & Co.
HealthEquity (NASDAQ:HQY – Free Report) had its price target decreased by JPMorgan Chase & Co. from $81.00 to $73.00 in a report released on Friday morning, Benzinga reports. JPMorgan Chase & Co. currently has an overweight rating on the stock. A number of other equities research analysts also recently weighed in on the company. StockNews.com […]
More Stories
Stryker Co. (NYSE:SYK) Shares Sold by Meeder Advisory Services Inc.
Meeder Advisory Services Inc. cut its stake in Stryker Co. (NYSE:SYK – Free Report) by 3.4% in the third quarter,...
Meeder Advisory Services Inc. Purchases 42 Shares of S&P Global Inc. (NYSE:SPGI)
Meeder Advisory Services Inc. raised its stake in shares of S&P Global Inc. (NYSE:SPGI – Free Report) by 0.8% during...
Investment Analysts’ Recent Ratings Updates for Allogene Therapeutics (ALLO)
Allogene Therapeutics (NASDAQ: ALLO) has recently received a number of price target changes and ratings updates: 11/14/2024 – Allogene Therapeutics...
Cisco Reports 4th Consecutive Revenue Decline, Looks to AI for Growth Revival
By Panos Mourdoukoutas Cisco Systems is well positioned to capitalize on the opportunity in artificial intelligence (AI) to revive sales...
Wirtual (WIRTUAL) Trading Up 83.8% Over Last Week
Wirtual (WIRTUAL) traded 4.2% lower against the U.S. dollar during the 1 day period ending at 12:00 PM E.T. on...
Wanchain 1-Day Volume Hits $2.35 Million (WAN)
Wanchain (WAN) traded 0.3% lower against the US dollar during the one day period ending at 12:00 PM ET on...